How many insider trades does FilingIQ track for JNCE?

FilingIQ tracks 167 Form 4 insider transactions for JNCE (Jounce Therapeutics, Inc.), covering filings from Feb 1, 2017 onwards. 0 of those are dated within the last 90 days.

Are JNCE insiders net buyers or net sellers?

Across the full Form 4 history for JNCE, 6 transactions (4%) were open-market purchases and 89 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does JNCE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

JNCE insider trading

CIK 1640455

Jounce Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades

167

Last 90 days

Buys / sells

4% / 53%

Insiders

JNCE insider activity at a glance

FilingIQ tracks 167 insider transactions for JNCE in filings since Feb 1, 2017. The most recent transaction is dated May 3, 2023. They were reported by 20 insiders.

Across the full history, 6 open-market purchases and 89 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Open JNCE on FilingIQ Raw filings on SEC EDGAR

Latest JNCE Form 4 filings

Concentra Biosciences, LLC

Drapkin Kimberlee C President, CFO and Treasurer

DU May 4, 2023

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to JNCE by Form 4 lines in the last 90 days, the number on each card.

LIGHTPATH TECHNOLOGIES INC

HBP 0

HUTTIG BUILDING PRODUCTS INC

TSP 0

TuSimple Holdings Inc.

VERO 0

Venus Concept Inc.

Frequently asked

How many insider trades does FilingIQ track for JNCE?: FilingIQ tracks 167 Form 4 insider transactions for JNCE (Jounce Therapeutics, Inc.), covering filings from Feb 1, 2017 onwards. 0 of those are dated within the last 90 days.
Are JNCE insiders net buyers or net sellers?: Across the full Form 4 history for JNCE, 6 transactions (4%) were open-market purchases and 89 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does JNCE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every JNCE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.